Regulatory uncertainty hangs over the entire marijuana sector. Outlook Pot Stocks: A gateway drug to portfolio losses?
Retrophin is the Hedged Value portfolio's largest holding. Strategies Retrophin’s record asset sales enhance outlook
High-flying GoPro faces future challenges. Apple cam, anyone? Strategies A skeptic’s take on tech darling GoPro
A majority of older Americans plan to work during their retirement years. Outlook How retirement expectations change with time
Rising rates and a stronger economy bode well for bank stocks. Outlook Why bank stocks are back in favor
Rising interest rates shouldn't be a reason for panic. Strategies Why the US remains best game in town
A flat market, weak earnings and aging expansion make me nervous. Strategies Why I’m anxious about stocks
In a surprise, Peltz group didn't pick up a single board seat. Outlook Strategies DuPont investors reject Peltz-led board seat battle
In this market, buy-and-hold tactics may not be as effective as in the past. Outlook What you need to know about stocks, right now
NASDAQ broke above 5,000 for the first time since March of 2000. Outlook Strategies Nasdaq and mid-caps have delivered in 2015
We also reduced allocations to finance and healthcare sectors. Strategies Upping our exposure to technology and utilities
